Search Results

The rotavirus W179-9 vaccine [RotaTeq] may not be associated with an elevated risk of Kawasaki's syndrome

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 7-7(1)

Publisher: Adis International

High incidence of pneumonitis with mTOR inhibitors

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 5-5(1)

Publisher: Adis International

GI ulcer incidence lower with P400 than naproxen

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 5-5(1)

Publisher: Adis International

Long-term use of dienogest for the treatment of endometriosis

Authors: Momoeda, Mikio; Harada, Tasuku; Terakawa, Naoki; Aso, Takeshi; Fukunaga, Masao; Hagino, Hiroshi; Taketani, Yuji

Source: The Journal of Obstetrics and Gynaecology Research, Volume 35, Number 6, December 2009 , pp. 1069-1076(8)

Publisher: Blackwell Publishing

The overall incidence of thrombocytopenia associated with linezolid is low among Veterans' Affairs patients

Source: Reactions, Volume 1, Number 1281, 2009-12-05 , pp. 5-5(1)

Publisher: Adis International

Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole

Authors: Grün, Barbara; Krautter, Stefanie; Riedel, Klaus-Dieter; Mikus, Gerd

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 712-720(9)

Publisher: Blackwell Publishing

Pharmacogenetics of Asthma Therapy

Authors: Duan, Qing L.; Tantisira, Kelan G.

Source: Current Pharmaceutical Design, Volume 15, Number 32, November 2009 , pp. 3742-3753(12)

Publisher: Bentham Science Publishers

Variability in MI incidence casts doubt on large trials

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 1-1(1)

Publisher: Adis International

Misoprostol cotherapy can reduce the incidence of NSAID-induced small-intestinal lesions

Source: Reactions, Volume 1, Number 1266, 2009-08-22 , pp. 5-5(1)

Publisher: Adis International

Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?

Author: Lugaresi, Alessandra

Source: Expert Opinion on Drug Delivery, Volume 6, Number 9, September 2009 , pp. 995-1002(8)

Publisher: Informa Healthcare

Olmesartan medoxomil: recent clinical and experimental acquisitions

Authors: Destro, Maurizio; Preti, Paola; D'Ospina, Antonio; Christian Achiri, Ngu Njwe; Ricci, Alessandra Rossi; Cagnoni, Francesca

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 9, September 2009 , pp. 1149-1157(9)

Publisher: Informa Healthcare

Prospective observational study of adverse drug reactions to diclofenac in children

Authors: Standing, Joseph F.; Ooi, Kuan; Keady, Simon; Howard, Richard F.; Savage, Imogen; Wong, Ian C. K.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 2, August 2009 , pp. 243-251(9)

Publisher: Blackwell Publishing

Hospitalizations because of Adverse Drug Reactions in Elderly Patients Admitted through the Emergency Department: A Prospective Survey

Authors: Olivier, Pascale; Bertrand, Lionel; Tubery, Marie; Lauque, Dominique; Montastruc, Jean-Louis; Lapeyre-Mestre, Maryse

Source: Drugs & Aging, Volume 26, Number 6, 6 June 2009 , pp. 475-482(8)

Publisher: Adis International

IBD incidence 100 times higher in JIA patients receiving etanercept

Source: Reactions, Volume 1, Number 1260, 2009-07-11 , pp. 3-3(1)

Publisher: Adis International

Prospective audit of the effectiveness of hydrocortisone premedication on drug delivery reactions following amphotericin B lipid complex*

Authors: O'Connor, Nigel; Borley, Ann

Source: Current Medical Research and Opinion, Volume 25, Number 3, March 2009 , pp. 749-754(6)

Publisher: Informa Healthcare

Once-daily insulin detemir in a cohort of insulin-naïve patients with type 2 diabetes: a sub-analysis from the PREDICTIVE study

Authors: Meneghini, L. F.; Dornhorst, A.; Sreenan, S.

Source: Current Medical Research and Opinion, Volume 25, Number 4, April 2009 , pp. 1029-1035(7)

Publisher: Informa Healthcare

Treatment of Chronic Non-Malignant Pain in the Elderly: Safety Considerations

Authors: >Jonathan Bruce Barber,; Gibson, Stephen J.

Source: Drug Safety, Volume 32, Number 6, 21 May 2009 , pp. 457-474(18)

Publisher: Adis International

Safety and Drug Utilization Profile of Varenicline as Used in General Practice in England: Interim Results from a Prescription-Event Monitoring Study

Authors: Kasliwal, Rachna; Wilton, Lynda V.; Shakir, Saad A.W.

Source: Drug Safety, Volume 32, Number 6, 21 May 2009 , pp. 499-507(9)

Publisher: Adis International

Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele

Authors: Charli-Joseph, Y; Cruz-Fuentes, C; Orozco-Topete, R

Source: Journal of the European Academy of Dermatology & Venereology, Volume 23, Number 7, July 2009 , pp. 788-792(5)

Publisher: Blackwell Publishing

Determination of the Frequency and Direct Cost of the Adverse Drug Events in Argentina

Authors: Izquierdo, Estela; Rodriguez, Claudio; Pampliega, Eneas; Filinger, Ester

Source: Current Drug Safety, Volume 4, Number 2, May 2009 , pp. 103-106(4)

Publisher: Bentham Science Publishers